Patient spotlight

Conversation with Lisa McNeil

This month, we spoke with Lisa McNeil, Chair of the Aspergillosis Trust and member of the ELF Aspergillosis Patient Advisory Group. Lisa shared highlights of her involvement in ELF activities this year, from co-chairing the first ELF Aspergillosis Patient Conference to attending the ERS Congress as a patient representative, and discussed her hopes for 2026.

15/12/2025

Can you tell us a bit about yourself and your condition?  

My name is Lisa, and I live with aspergillus bronchitis alongside bronchiectasis and cardiomyopathy.  Managing a long-term respiratory condition has shaped every part of my life, from giving up my job, missing out on family occasions to pacing my energy and dealing with flare-ups. Navigating the emotional and practical challenges that come with a chronic illness has been challenging.   

I was part of a small group of patients who came together to create the charity the Aspergillosis Trust and I now serve as its Chair. Having lived experience allows me to advocate with authenticity and compassion, ensuring our work stays grounded in the realities that patients face. Over the last year especially, I have felt incredibly proud of what we have achieved as a community-led charity. 

How did you first learn you had aspergillosis, and how has your journey been since then?  

My diagnosis came after a long period of repeated infections that required hospital stays.  Like many others, I knew there was something going on that was not being fully understood. I got a second opinion and was referred to the National Aspergillosis Centre in Wythenshawe, Manchester (UK). When the aspergillus bronchitis diagnosis was finally confirmed, it brought both relief at having an answer and a huge sense of uncertainty about what the future would look like. 

Since then, my journey has been a mix of difficult days and hopeful ones. Learning to manage my condition, finding the right treatments and connecting with others living with aspergillus-related disease has been incredibly empowering. Over time, my personal experience has shifted into purpose and that continues to motivate everything I do.   

How did you get involved in patient advocacy?  

That is a really good question and I am not really sure. I think it just began naturally for me. I wanted to understand my own condition, but I also wanted to help others who were struggling with delayed diagnosis, limited awareness or the feeling of being dismissed and unheard. Becoming part of the team that founded the Aspergillosis Trust was a turning point. We created the charity because patients needed support, visibility and a voice. Over the years, my involvement has grown into shaping resources, speaking at conferences, contributing to research discussions and supporting people at every stage of their journey. It has been one of the most meaningful parts of my life.  

You recently co-chaired the ELF Aspergillosis Patient Conference. How was your experience?  

Co-chairing the conference was a real privilege. It was a day filled with thoughtful discussion and compassion. What stood out to me was how genuine the collaboration felt; patients, clinicians and researchers all leaning in, asking questions and sharing perspectives that complemented one another. Being able to guide conversations through the lens of lived experience helped make the event more relatable and emotionally grounded. It was an honour to help shape a space where so many people felt understood and supported.  

Why is it important for patients to be involved in hosting events like this?  

Patients bring honesty and real-life perspective and we remind the clinicians and researchers that this is what it is really about. Patients understand the daily impact of symptoms, medication side effects, fatigue and the emotional weight these conditions carry. When Marcela described what it is like to live with this condition I was honestly moved to tears. Her story was so honest and raw and yet she is out here doing the same as me, desperate to ensure that others have a better journey than we did.    

When patients help host or shape an event, the focus naturally becomes more human, more connected to the realities people are living with. It also reassures attendees that their voices matter and that they are not alone. Our presence strengthens the relevance and compassion of every session.  

As a member of the Aspergillosis Patient Advisory Group, you have been involved in a number of events with us this year, including the ERS Congress. What have been your highlights of 2025 and why?  

2025 has been an exceptional year both personally and for the charity. Several highlights come to mind: 

  • Taking part in the ERS Congress Studio session “Bridging the Communication Gap”.  Being in the studio and contributing to such a forward-thinking discussion was incredibly inspiring. It highlighted how vital good communication is between patients and healthcare professionals, and it felt empowering to represent our community in that space. 
  • Attending the wider ERS Congress which reminded me how much dedication and innovation there is in respiratory research, and the ELF Patient Organisation Networking Day, connecting with other patients, sharing stories, and learning from each other reinforced how powerful community can be. 
  • The launch of our children’s book “Dad and the Sneaky Spores”. This has been one of the things I am most proud of this year. It is a gentle, accessible way to help children understand aspergillus-related illness within their family but also living with a chronic lung condition and how this helps to shape family life. Taking the book into schools, seeing it come to life and hearing the positive feedback from both parents and children has meant the world. 
  • Our charity’s continued growth, from awareness campaigns to support initiatives, it feels like we’ve taken real steps forward this year. 
  • And finally, our Christmas Tree Festival entry “Holding on to Hope.” The tree features heartfelt messages of hope from patients and beautifully crafted memorial baubles for those we have lost. It is a powerful, emotional reminder of why we do this work and the community we represent. 

What advice would you give to people who are interested in becoming a patient advocate or joining a PAG?  

Start with what feels comfortable and meaningful to you. Advocacy is not about being an expert and knowing everything, it is about sharing your experience, offering support where you can and using your voice to make life better for yourself and for others. Joining a PAG is a wonderful first step. It gives you and a group of people who truly understand what you have lived through. Every perspective matters and even small contributions can make a real change. 

What are your hopes for 2026?  

Gosh, that is a hard one as I have so many! I hope 2026 brings even more opportunities for genuine collaboration between patients, clinicians and researchers. I would love to see: 

  • Greater awareness of aspergillus-related disease  
  • More accessible information around diagnostics and antifungal resistance 
  • Further growth for the Aspergillosis Trust, including new initiatives, stronger outreach and more support for families.   
  • On a personal level, I hope my health remains steady enough for me to keep doing this work, because it is something I am deeply passionate about. 

Would you like to add anything else?  

I would simply like to say how proud I am of our community. The strength and resilience I see in patients and families is extraordinary. This year in particular has shown what we can achieve when we come together, from publishing a children’s book to hosting meaningful awareness events, to honouring those we have lost through our “Holding on to Hope” tree.  

I am grateful to ELF for continually involving patients as equal partners and for helping ensure our voices shape the future of aspergillus related care. Together, we are creating real change and I feel honoured to be a part of it.